A novel transmembrane CXCR4 variant that expands the WHIM genotype-phenotype paradigm

Affiliations

• ¹ X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria.
• ² Formerly X4 Pharmaceuticals (Austria) GmbH, Vienna, Austria.
• ³ Research Department, Belarusian Research Center for Pediatric Oncology, Hematology, and Immunology, Minsk, Belarus.
• ⁴ Department of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
• ⁵ Center for Chronic Immunodeficiency, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
• ⁶ X4 Pharmaceuticals, Boston, MA.
• ⁷ Division of Allergy, Immunology, Department of Pediatrics, Duke University School of Medicine, Durham, NC.
• ⁸ Department of Rheumatology and Clinical Immunology, Hannover Medical School, Hannover, Germany.
• ⁹ RESIST-Cluster of Excellence 2155, Hannover Medical School, Hannover, Germany.
• ¹⁰ Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
• ¹¹ Division of Allergy and Immunology, Department of Medicine, Johns Hopkins All Children's Hospital, St Petersburg, FL.
• ¹² Division of Allergy & Immunology, Department of Pediatrics, Morsani College of Medicine, University of South Florida, Tampa, FL.
• ¹³ Division of Allergy and Immunology, Massachusetts General Hospital for Children, Boston, MA.
• ¹⁴ Division of Hematopathology, Department of Pathology, Duke University, Durham, NC.
• ¹⁵ Department of Pathology, Boston Children's Hospital, Boston, MA.
• ¹⁶ Division of Rheumatology and Immunology, Department of Medicine, Duke University, Durham, NC.
• ¹⁷ Durham Veterans Affairs Medical Center, Durham, NC.